11466698

Source:http://linkedlifedata.com/resource/pubmed/id/11466698

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002199, umls-concept:C0007257, umls-concept:C0017638, umls-concept:C0030705, umls-concept:C0087111, umls-concept:C0282461, umls-concept:C1518321, umls-concept:C1522449
pubmed:issue	2
pubmed:dateCreated	2001-7-23
pubmed:abstractText	The current study was conducted to determine whether the addition of interferon-alpha (IFN-alpha) to treatment with radiation therapy and carmustine (BCNU) improves time to disease progression or overall survival in patients with high-grade glioma.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA-15083, http://linkedlifedata.com/resource/pubmed/grant/CA-25224, http://linkedlifedata.com/resource/pubmed/grant/CA-35101, http://linkedlifedata.com/resource/pubmed/grant/CA-35103, http://linkedlifedata.com/resource/pubmed/grant/CA-35113, http://linkedlifedata.com/resource/pubmed/grant/CA-35195, http://linkedlifedata.com/resource/pubmed/grant/CA-35269, http://linkedlifedata.com/resource/pubmed/grant/CA-35272, http://linkedlifedata.com/resource/pubmed/grant/CA-35415, http://linkedlifedata.com/resource/pubmed/grant/CA-35448, http://linkedlifedata.com/resource/pubmed/grant/CA-37404, http://linkedlifedata.com/resource/pubmed/grant/CA-37417, http://linkedlifedata.com/resource/pubmed/grant/CA-52352, http://linkedlifedata.com/resource/pubmed/grant/CA-60276, http://linkedlifedata.com/resource/pubmed/grant/CA-63849
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Alkylating, http://linkedlifedata.com/resource/pubmed/chemical/Carmustine, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0008-543X
pubmed:author	pubmed-author:BernathA MAM, pubmed-author:BucknerJ CJC, pubmed-author:CascinoT LTL, pubmed-author:ColeJ TJT, pubmed-author:HatfieldA KAK, pubmed-author:KurossS ASA, pubmed-author:MailliardJ AJA, pubmed-author:McGinnisW LWL, pubmed-author:MortonR FRF, pubmed-author:O'FallonJ RJR, pubmed-author:ScheithauerB WBW, pubmed-author:SchombergP JPJ, pubmed-author:SteenP DPD
pubmed:copyrightInfo	Copyright 2001 American Cancer Society.
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	92
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	420-33
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:11466698-Adult, pubmed-meshheading:11466698-Aged, pubmed-meshheading:11466698-Antineoplastic Agents, pubmed-meshheading:11466698-Antineoplastic Agents, Alkylating, pubmed-meshheading:11466698-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11466698-Brain Neoplasms, pubmed-meshheading:11466698-Carmustine, pubmed-meshheading:11466698-Combined Modality Therapy, pubmed-meshheading:11466698-Disease Progression, pubmed-meshheading:11466698-Female, pubmed-meshheading:11466698-Glioma, pubmed-meshheading:11466698-Humans, pubmed-meshheading:11466698-Interferon-alpha, pubmed-meshheading:11466698-Male, pubmed-meshheading:11466698-Middle Aged, pubmed-meshheading:11466698-Neoplasm Staging, pubmed-meshheading:11466698-Survival Analysis, pubmed-meshheading:11466698-Treatment Outcome
pubmed:year	2001
pubmed:articleTitle	A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.
pubmed:affiliation	Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA. buckner.jan@mayo.edu
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III